DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

60.28 -1.81 (-2.92%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $60.28 -2.92%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.53
Previous Close $62.09
Daily Range $60.03 - $61.93
52-Week Range $51.92 - $63.62
Market Cap $171.9B
P/E Ratio 33.74
Dividend (Yield) $1.80 (2.9%)
Ex-Dividend Date
Dividend Pay Date
12/11/14
01/08/15
Volume 12,072,409
Average Daily Volume 10,897,666
Current FY EPS $3.48

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

Can Biotech Duplicate Its 2014 Performance, or Is It Time to Jump Ship?

Three Motley Fool healthcare contributors share thoughts on whether biotech stocks can go higher this year.

Earnings Expectations For The Week Of February 2: Disney, Exxon, GM And More

Gasoline ‘tax cut’ in focus on energy, consumer-based earnings

The Top 10 Corporate Earnings for the Week Ahead

Big Pharma: An Up-Close Look at One Key Player

Industry Focus zooms in on restructuring, new drugs, and possible threats for pharma giant Novartis.

What Investors Are Watching For In Regulus Therapeutics' Next Data Release

Regeneron Shows Biotech Investors Have Left Their Wildcatting Days

Here are the drivers of future economic growth

Franchise Fortunes Mark Shifts In Consensus For Marketed Products

Bristol-Myers Squibb Earnings: Currency Headwinds Take The Shine Off Encouraging New Drug Sales

See More MRK News...

MRK's Top Competitors

MRK $60.28 (-2.92%)
Current stock: MRK
JNJ $100.14 (-2.19%)
Current stock: JNJ
NVS $97.40 (-1.77%)
Current stock: NVS
RHHBY $33.78 (-1.75%)
Current stock: RHHBY